Literature DB >> 2795681

Mycosis fungoides in relation to environmental exposures and immune response: a case-control study.

A S Whittemore1, E A Holly, I M Lee, E A Abel, R M Adams, B J Nickoloff, L Bley, J M Peters, C Gibney.   

Abstract

Mycosis fungoides is a cutaneous T-cell lymphoma of unknown etiology, thought to be a rare sequela of chronic antigenic stimulation that may occur, for example, with exposure to contact allergens. To explore this possibility, we interviewed 174 patients with mycosis fungoides and 294 randomly selected control subjects in the San Francisco, Los Angeles, and Seattle areas concerning their lifetime histories of employment, chemical exposures, allergy, atopy, and certain medical conditions. Patients reported higher prevalence of cancers other than the non-Hodgkin's lymphomas and skin cancers (relative risk = 3.3, P less than .001) and were more likely than controls to burn when exposed to the sun (for nonblacks, relative risk = 1.7, P = .01). The latter difference may reflect a manifestation rather than a precursor of the disease. We found no consistent or biologically plausible differences between patients and controls with respect to types of jobs held, or to occupational or vocational exposures to chemicals. These findings do not support the hypothesis that persistent antigenic stimulation by contact allergens is etiologically important in the pathogenesis of mycosis fungoides.

Entities:  

Mesh:

Year:  1989        PMID: 2795681     DOI: 10.1093/jnci/81.20.1560

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

Review 1.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

2.  Peripheral T-cell lymphoma and Job's syndrome: a rare association.

Authors:  Ibrahim K Onal; Mevlut Kurt; Kadri Altundag; Sercan Aksoy; Murat Dincer; Ibrahim Gullu
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Ophthalmic abnormalities in patients with cutaneous T-cell lymphoma.

Authors:  B E Cook; G B Bartley; M R Pittelkow
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 4.  Infectious agents in cutaneous T-cell lymphoma.

Authors:  Ezra D Mirvish; Rebecca G Pomerantz; Larisa J Geskin
Journal:  J Am Acad Dermatol       Date:  2010-08-07       Impact factor: 11.527

5.  Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Briseis Aschebrook-Kilfoy; Pierluigi Cocco; Carlo La Vecchia; Ellen T Chang; Claire M Vajdic; Marshall E Kadin; John J Spinelli; Lindsay M Morton; Eleanor V Kane; Joshua N Sampson; Carol Kasten; Andrew L Feldman; Sophia S Wang; Yawei Zhang
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

Review 6.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

7.  Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study.

Authors:  J Iscovich; O Paltiel; E Azizi; A Kuten; A Gat; B Lifzchitz-Mercer; A Zlotogorski; A Polliack
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

8.  Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).

Authors:  M Thayu; G Tallini; E J Glusac; B M Kacinski; L D Wilson
Journal:  Yale J Biol Med       Date:  1999 Nov-Dec

9.  Mycosis fungoides: case report and literature review.

Authors:  Akinsegun A Akinbami; Bodunrin I Osikomaiya; Sarah O John-Olabode; Adewumi A Adediran; Olajumoke Osinaike; Ebele I Uche; Ayobami K Ismail; Adedoyin O Dosunmu; Mojeed Odesanya; Akinola Dada; Olaitan Okunoye
Journal:  Clin Med Insights Case Rep       Date:  2014-09-03

10.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.